Goblet cell carcinoid, now goblet cell adenocarcinoma, masquerading as acute appendicitis: Case report of an uncommon clinical presentation and a brief review of the literature

A goblet cell carcinoid (GCC) is an appendiceal neoplasm with mixed neuroendocrine and glandular differentiation that is uncommon and most typically affects middle-aged adults. The terminology of this tumor has recently been changed to goblet cell adenocarcinoma (GCA) to indicate the malignant behavior of this tumor, which is more than that of a neuroendocrine tumor (NET). The WHO has removed the term “carcinoid” in naming tumors in its 2022 classification. In this report, we present a 42-year-old man who was admitted to the hospital with complaints of severe pain in the right lower abdomen, fever, and elevated white blood cells, which were the common symptoms of acute appendicitis. He had a scheduled appendectomy and thought that he would recover like any other normal case. However, what was unexpected was the pathology report, which showed goblet cell adenocarcinoma (GCA), a rare and aggressive tumor that was previously known as GCC. In contrast to the general NETs, GCC acts rather like an adenocarcinoma, inclining to invade the adjacent tissues and metastasize. Here, the tumor has extended beyond the appendix and invaded the surrounding fat (T3N0M0, Stage IIA). The fat invasion also necessitated continued treatment, whereas the lymph nodes and distant organs were not affected. The carcinoid/adenocarcinoma terminology transformation signifies the actual nature of the tumor, which is more of a rapidly progressing cancer that needs vigorous treatment rather than a NET with a slow growth rate. This case serves as a reminder to keep a wide differential diagnosis, even in classical presentations, such as appendicitis. Cross-disciplinary tumor board discussion was key in decision-making regarding the treatment plan. Four years after surgery, the patient is still disease-free. We provide a brief literature review on this uncommon tumor and clarify the recent change in classification terminology.

Authors

Publication Details

Journal
GSC Advanced Research and Reviews
Published
2025-08-09
DOI
https://doi.org/10.30574/gscarr.2025.24.2.0224
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Goblet cell carcinoid, now goblet cell adenocarcinoma, masquerading as acute appendicitis: Case report of an uncommon clinical presentation and a brief review of the literature

Sabry S. Ayad, Manel Marzouk, À. Rovira Cañellas, Oliver Stewart et al.
GSC Advanced Research and Reviews
Neuroendocrine Tumor Research Advances
article

Goblet cell carcinoid, now goblet cell adenocarcinoma, masquerading as acute appendicitis: Case report of an uncommon clinical presentation and a brief review of the literature

Sabry S. Ayad, Manel Marzouk, À. Rovira Cañellas, Oliver Stewart, Natalija Novak, Mohammed Aziz, Mariam F. Ayad, Anthony Bonilla, Jessica Jahoda, Fatima Almusawi
article en

Abstract

A goblet cell carcinoid (GCC) is an appendiceal neoplasm with mixed neuroendocrine and glandular differentiation that is uncommon and most typically affects middle-aged adults. The terminology of this tumor has recently been changed to goblet cell adenocarcinoma (GCA) to indicate the malignant behavior of this tumor, which is more than that of a neuroendocrine tumor (NET). The WHO has removed the term “carcinoid” in naming tumors in its 2022 classification. In this report, we present a 42-year-old man who was admitted to the hospital with complaints of severe pain in the right lower abdomen, fever, and elevated white blood cells, which were the common symptoms of acute appendicitis. He had a scheduled appendectomy and thought that he would recover like any other normal case. However, what was unexpected was the pathology report, which showed goblet cell adenocarcinoma (GCA), a rare and aggressive tumor that was previously known as GCC. In contrast to the general NETs, GCC acts rather like an adenocarcinoma, inclining to invade the adjacent tissues and metastasize. Here, the tumor has extended beyond the appendix and invaded the surrounding fat (T3N0M0, Stage IIA). The fat invasion also necessitated continued treatment, whereas the lymph nodes and distant organs were not affected. The carcinoid/adenocarcinoma terminology transformation signifies the actual nature of the tumor, which is more of a rapidly progressing cancer that needs vigorous treatment rather than a NET with a slow growth rate. This case serves as a reminder to keep a wide differential diagnosis, even in classical presentations, such as appendicitis. Cross-disciplinary tumor board discussion was key in decision-making regarding the treatment plan. Four years after surgery, the patient is still disease-free. We provide a brief literature review on this uncommon tumor and clarify the recent change in classification terminology.

GSC Advanced Research and ReviewsVol. 24(2)
Good health and well-being
Openalex Percentile: Top 71%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.